These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 25811302)

  • 21. Prevalence of hepatitis E virus RNA and antibodies in a cohort of kidney transplant recipients in Central Brazil.
    de Oliveira JMNS; Freitas NR; Teles SA; Bottino FO; Lemos AS; de Oliveira JM; de Paula V; Pinto MA; Martins RMB
    Int J Infect Dis; 2018 Apr; 69():41-43. PubMed ID: 29408465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis E virus immunoglobulin G antibodies in different populations in Campinas, Brazil.
    Gonçales NS; Pinho JR; Moreira RC; Saraceni CP; Spina AM; Stucchi RB; Filho AD; Magna LA; Gonçales Júnior FL
    Clin Diagn Lab Immunol; 2000 Sep; 7(5):813-6. PubMed ID: 10973460
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatitis E virus seroprevalence among adults, Germany.
    Faber MS; Wenzel JJ; Jilg W; Thamm M; Höhle M; Stark K
    Emerg Infect Dis; 2012 Oct; 18(10):1654-7. PubMed ID: 23018055
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Seroprevalence and risk factors of hepatitis E virus infection in cancer patients in eastern China.
    Bai MJ; Zhou N; Dong W; Li GX; Cong W; Zhu XQ
    Int J Infect Dis; 2018 Jun; 71():42-47. PubMed ID: 29656134
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatitis E in Israel: A nation-wide retrospective study.
    Erez-Granat O; Lachish T; Daudi N; Shouval D; Schwartz E
    World J Gastroenterol; 2016 Jun; 22(24):5568-77. PubMed ID: 27350735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seroprevalence of fecal-oral transmitted hepatitis A and E virus antibodies in Burkina Faso.
    Traoré KA; Rouamba H; Nébié Y; Sanou M; Traoré AS; Barro N; Roques P
    PLoS One; 2012; 7(10):e48125. PubMed ID: 23110187
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HEV infection in French HIV-infected patients.
    Abravanel F; Lhomme S; Fougère M; Saune K; Alvarez M; Péron JM; Delobel P; Izopet J
    J Infect; 2017 Mar; 74(3):310-313. PubMed ID: 27998748
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of hepatitis E virus seroprevalence between HBsAg-positive population and healthy controls in Shandong province, China.
    Zhang L; Jiang Z; Lv J; Liu J; Yan B; Feng Y; Li L; Zhang G; Wang F; Xu A
    BMC Infect Dis; 2018 Feb; 18(1):75. PubMed ID: 29433428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Test performance characteristics of Anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates.
    Wenzel JJ; Preiss J; Schemmerer M; Huber B; Jilg W
    J Infect Dis; 2013 Feb; 207(3):497-500. PubMed ID: 23148290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of hepatitis E virus viremia and antibodies among healthy blood donors in India.
    Katiyar H; Goel A; Sonker A; Yadav V; Sapun S; Chaudhary R; Aggarwal R
    Indian J Gastroenterol; 2018 Jul; 37(4):342-346. PubMed ID: 30159666
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroprevalence of hepatitis E virus in an adult urban population from Burundi.
    Aubry P; Niel L; Niyongabo T; Kerguelen S; Larouze B
    Am J Trop Med Hyg; 1997 Sep; 57(3):272-3. PubMed ID: 9311635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of hepatitis E virus in Chinese blood donors.
    Guo QS; Yan Q; Xiong JH; Ge SX; Shih JW; Ng MH; Zhang J; Xia NS
    J Clin Microbiol; 2010 Jan; 48(1):317-8. PubMed ID: 19940058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis E virus infection: An underdiagnosed infection in transplant patients in Southern Africa?
    Andersson MI; Stead PA; Maponga T; van der Plas H; Preiser W
    J Clin Virol; 2015 Sep; 70():23-25. PubMed ID: 26305814
    [No Abstract]   [Full Text] [Related]  

  • 34. Hepatitis E Virus (HEV) Infection in Anti-HEV Immunoglobulin G-Carrying Patients After Successful Hepatitis C Virus Treatment: Reactivation or Reinfection?
    Rivero-Juarez A; Frias M; Lopez-Lopez P; de Los Angeles Risalde M; Brieva T; Machuca I; Camacho A; Martinez-Peinado A; Gomez-Villamandos JC; Rivero A
    Clin Infect Dis; 2017 Apr; 64(7):964-966. PubMed ID: 28077520
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroepidemiology and molecular characterization of hepatitis E virus in Jilin, China.
    Zhu G; Qu Y; Jin N; Sun Z; Liu T; Lee H; Tian M; Wang T
    Infection; 2008 Mar; 36(2):140-6. PubMed ID: 18330507
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis E virus infection in Hong Kong blood donors.
    Tsoi WC; Zhu X; To AP; Holmberg J
    Vox Sang; 2020 Jan; 115(1):11-17. PubMed ID: 31709559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis E virus co-infection in HIV-infected patients in Foggia and Naples in southern Italy.
    Scotto G; Grisorio B; Filippini P; Ferrara S; Massa S; Bulla F; Martini S; Filippini A; Tartaglia A; Lo Muzio L; Fazio V
    Infect Dis (Lond); 2015; 47(10):707-13. PubMed ID: 25994453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of hepatitis E virus infection in children in the northeast of Spain.
    Buti M; Plans P; Domínguez A; Jardi R; Rodriguez Frias F; Esteban R; Salleras L; Plasencia A
    Clin Vaccine Immunol; 2008 Apr; 15(4):732-4. PubMed ID: 18321881
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous decline of hepatitis E virus seroprevalence in southern Germany despite increasing notifications, 2003-2015.
    Mahrt H; Schemmerer M; Behrens G; Leitzmann M; Jilg W; Wenzel JJ
    Emerg Microbes Infect; 2018 Jul; 7(1):133. PubMed ID: 30042475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Seroprevalence and risk factors of hepatitis E virus infection among children in China.
    Meng QF; You HL; Wang WL; Zhou N; Dong W; Cong W
    J Med Virol; 2015 Sep; 87(9):1573-7. PubMed ID: 25940435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.